N-(Hetero)aryl-2-imidazolines: An emerging privileged motif for contemporary drug design

Mikhail Krasavin

Результат исследований: Научные публикации в периодических изданиях › Обзорная статья

6 Цитирования (Scopus)

Выдержка

(Figure Presented) The diverse biological activities of compounds containing N-(hetero)aryl-2-imidazoline moiety and methods to construct them are comprehensively reviewed for the first time. This intriguing non-flat, cyclic amidine motif clearly represents an emerging privileged structure.

Язык оригиналаанглийский
Страницы (с-по)240-255
Число страниц16
ЖурналChemistry of Heterocyclic Compounds
Том53
Номер выпуска3
DOI
СостояниеОпубликовано - 1 мар 2017

Отпечаток

Amidines
Bioactivity
Pharmaceutical Preparations
2-imidazoline

Предметные области Scopus

  • Органическая химия

Цитировать

Krasavin, Mikhail. / N-(Hetero)aryl-2-imidazolines : An emerging privileged motif for contemporary drug design. В: Chemistry of Heterocyclic Compounds. 2017 ; Том 53, № 3. стр. 240-255.
@article{183882f49a18468abe928a96180b567d,
title = "N-(Hetero)aryl-2-imidazolines: An emerging privileged motif for contemporary drug design",
abstract = "(Figure Presented) The diverse biological activities of compounds containing N-(hetero)aryl-2-imidazoline moiety and methods to construct them are comprehensively reviewed for the first time. This intriguing non-flat, cyclic amidine motif clearly represents an emerging privileged structure.",
keywords = "Cyclodehydration, Imidazoline N-arylation, Lead-like compounds, Privileged structures",
author = "Mikhail Krasavin",
year = "2017",
month = "3",
day = "1",
doi = "10.1007/s10593-017-2047-3",
language = "English",
volume = "53",
pages = "240--255",
journal = "Chemistry of Heterocyclic Compounds",
issn = "0009-3122",
publisher = "Springer",
number = "3",

}

Krasavin, M 2017, 'N-(Hetero)aryl-2-imidazolines: An emerging privileged motif for contemporary drug design', Chemistry of Heterocyclic Compounds, том. 53, № 3, стр. 240-255. https://doi.org/10.1007/s10593-017-2047-3

N-(Hetero)aryl-2-imidazolines : An emerging privileged motif for contemporary drug design. / Krasavin, Mikhail.

В: Chemistry of Heterocyclic Compounds, Том 53, № 3, 01.03.2017, стр. 240-255.

Результат исследований: Научные публикации в периодических изданиях › Обзорная статья

TY - JOUR

T1 - N-(Hetero)aryl-2-imidazolines

T2 - An emerging privileged motif for contemporary drug design

AU - Krasavin, Mikhail

PY - 2017/3/1

Y1 - 2017/3/1

N2 - (Figure Presented) The diverse biological activities of compounds containing N-(hetero)aryl-2-imidazoline moiety and methods to construct them are comprehensively reviewed for the first time. This intriguing non-flat, cyclic amidine motif clearly represents an emerging privileged structure.

AB - (Figure Presented) The diverse biological activities of compounds containing N-(hetero)aryl-2-imidazoline moiety and methods to construct them are comprehensively reviewed for the first time. This intriguing non-flat, cyclic amidine motif clearly represents an emerging privileged structure.

KW - Cyclodehydration

KW - Imidazoline N-arylation

KW - Lead-like compounds

KW - Privileged structures

UR - http://www.scopus.com/inward/record.url?scp=85018358082&partnerID=8YFLogxK

U2 - 10.1007/s10593-017-2047-3

DO - 10.1007/s10593-017-2047-3

M3 - Review article

AN - SCOPUS:85018358082

VL - 53

SP - 240

EP - 255

JO - Chemistry of Heterocyclic Compounds

JF - Chemistry of Heterocyclic Compounds

SN - 0009-3122

IS - 3

ER -

Krasavin M. N-(Hetero)aryl-2-imidazolines: An emerging privileged motif for contemporary drug design. Chemistry of Heterocyclic Compounds. 2017 Март 1;53(3):240-255. https://doi.org/10.1007/s10593-017-2047-3

Доступ к документам